Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
ENHIVEND
This is a promotional event sponsored by GSK ViiV
Embracing Their Vision to Bring About a Change for Everyone in the HIV Community
ViiV and The Leadership Forum are using science to envision the end of the HIV epidemic by 2030.
Watch this video to learn more about this programme.
ENHIVEND is a 2 stage programme
The Expert Leadership Forum
1
A collaborative hub for healthcare professionals across Ireland to design tailored HIV programmes. Participants review the latest data on novel therapies and local infrastructure, discuss practical implementation, and identify the specific information and resources each hospital needs. The Leadership Forum’s goal is to translate evidence into targeted, actionable strategies that strengthen HIV care and the treatment landscape.
In Hospital Vision 2030 Workshop
2
The Workshop builds on the foundations set at the Leadership Forum. In the in‑hospital session, each healthcare professional presents their tailored content to their own team, fostering a practical, peer-to-peer learning environment. This hands‑on approach prompts direct engagement and discussion among colleagues, while systematic feedback from attendees is collected to refine and strengthen clinic protocols. The Vision 2030 Workshop is the next phase of this continuous improvement cycle, uniting frontline insights and experience to accelerate the shared goal of ending the HIV epidemic by 2030.
A snapshot of the Expert Leadership Forum
The Expert Leadership Forum is divided into 4 Dimensions, representing the journey to Vision 2030.
DIMENSION ONE
Latest HIV Data & Improved Treatment Strategies
Our keynote speaker delves into DIMENSION ONE: THE PRESENT, REFLECTING ON INNOVATIONS IN HIV TREATMENT AND THEIR APPLICATION IN DAILY PRACTICE. The speaker shares their journey navigating through personal perceptions and conviction in the data, leading to changes in treatment protocols.
They provide examples of discussions and negotiations that are had with hospital colleagues to foster a shared purpose. They showcase successful collaborative team efforts as the driving force behind achieving KEY MILESTONES TO IMPROVE HIV CARE in the hospital.
VISUALISING DIMENSION TWO
DIMENSION TWO
Stepping into the Shoes of a PLHIV
Participants are immersed in VIRTUAL REALITY daily scenarios from the perspective of a person living with HIV (PLHIV). This provides valuable insights into the lived experiences of PLHIV, facilitating discussions on the impact of HIV-RELATED STIGMA AND DISCRIMINATION and addressing the key challenges they face.
VISUALISING DIMENSION THREE
DIMENSION THREE
Our Present, Our Challenges and Opportunities Workshop
Next, the group engages in “MY PRESENT JOURNEY”, a workshop that facilitates discussions of THE CURRENT CHALLENGES AND SUCCESSES IN HIV CARE. This includes a discussion of examples of patient case studies, current treatment methods, and the potential for ALTERNATIVE TREATMENTS in different circumstances.
VISUALISING DIMENSION FOUR
DIMENSION FOUR
The Route to Vision 2030
Finally, the attendees build on these insights and further explore their aspirations for HIV management and treatment. The group participates in the “CRAFTING MY 2030 VISION” WORKSHOP to address the key challenges in the HIV space and transform them into bespoke and concrete action plans and strategies.
Lastly, ViiV and the Leadership Forum conclude by exploring ENHIVEND's promising future, envisioning the programme's lasting impact to remain at the forefront of the global HIV response and to contribute to ending the epidemic by 2030.
Watch the highlights of the Leadership Forum below
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255, or via the online patient safety reportingform at gsk.public.reportum.com.
PM-IE-HVX-WCNT-250001
Date of preparation: February 2026
